James E Flynn Insider Trading $IVTY Invuity, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Over the past year James E Flynn has been an insider in 10 companies. The total value of shares held by James E Flynn in these companies amounts to $12,414,862.

James E Flynn 10% Owner
Aclaris Therapeutics, Inc.
Director
Acutus Medical, Inc.
Director
AdaptHealth Corp.
10% Owner
Adverum Biotechnologies, Inc.
10% Owner
ALIMERA SCIENCES INC
Director, 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
Annexon, Inc.
10% Owner
ANTARES PHARMA, INC.
10% Owner
ARENA PHARMACEUTICALS INC
10% Owner
ARVINAS, INC.
10% Owner
aTYR PHARMA INC
10% Owner
Audentes Therapeutics, Inc.
10% Owner
Auspex Pharmaceuticals, Inc.
10% Owner
AVADEL PHARMACEUTICALS PLC
Director
AveXis, Inc.
10% Owner
Axogen, Inc.
10% Owner
Black Diamond Therapeutics, Inc.
10% Owner
Cabaletta Bio, Inc.
10% Owner
CAS MEDICAL SYSTEMS INC
10% Owner
CATALYST BIOSCIENCES, INC.
10% Owner
CONSTELLATION PHARMACEUTICALS INC
10% Owner
Cyclacel Pharmaceuticals, Inc.
10% Owner
CytomX Therapeutics, Inc.
Director
Deerfield Healthcare Technology Acquisitions Corp.
Director
DFP HEALTHCARE ACQUISITIONS CORP.
10% Owner
Dicerna Pharmaceuticals Inc
10% Owner
DUSA PHARMACEUTICALS INC
10% Owner
DYNAVAX TECHNOLOGIES CORP
10% Owner
Edgewise Therapeutics, Inc.
10% Owner
Editas Medicine, Inc.
10% Owner
eHealth, Inc.
10% Owner
EMAGEON INC
10% Owner
Fibrocell Science, Inc.
10% Owner
Frequency Therapeutics, Inc.
10% Owner
Generation Bio Co.
10% Owner
HI TECH PHARMACAL CO INC
10% Owner, Director
Homology Medicines, Inc.
10% Owner
INSPIRE PHARMACEUTICALS INC
10% Owner
Invuity, Inc.
10% Owner
ISTA PHARMACEUTICALS INC
10% Owner
Kiniksa Pharmaceuticals, Ltd.
10% Owner
Larimar Therapeutics, Inc.
10% Owner
Loxo Oncology, Inc.
10% Owner
LUMOS PHARMA, INC.
10% Owner
Mallinckrodt plc
10% Owner
MEDICINES CO /DE
10% Owner
Mirum Pharmaceuticals, Inc.
10% Owner
Neos Therapeutics, Inc.
10% Owner
NeurogesX Inc
10% Owner
NeuroMetrix, Inc.
10% Owner
NITROMED INC
10% Owner
Nkarta, Inc.
10% Owner
NxStage Medical, Inc.
Director
Oncorus, Inc.
10% Owner
PAR PHARMACEUTICAL COMPANIES, INC.
Director
Protara Therapeutics, Inc.
10% Owner
Recro Pharma, Inc.
10% Owner
REGENXBIO Inc.
10% Owner
Revolution Medicines, Inc.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
RIGEL PHARMACEUTICALS INC
10% Owner
Schrodinger, Inc.
10% Owner
Shockwave Medical, Inc.
10% Owner
SteadyMed Ltd.
10% Owner
STREAMLINE HEALTH SOLUTIONS INC.
10% Owner
Syros Pharmaceuticals, Inc.
Director
Talon Therapeutics, Inc.
10% Owner
Terns Pharmaceuticals, Inc.
10% Owner
THIRD WAVE TECHNOLOGIES INC /WI
10% Owner
TriVascular Technologies, Inc.
10% Owner
Vanda Pharmaceuticals Inc.
10% Owner
VIA Pharmaceuticals, Inc.
10% Owner
Werewolf Therapeutics, Inc.
10% Owner
XENOPORT INC
10% Owner
XERIS PHARMACEUTICALS INC
$ 12414862 The total value of shares held by James E Flynn
Insider Rank

James E Flynn ranks 2,262 out of 350,000 insiders. Go to Insider Ranking to see more.

James E Flynn in Invuity, Inc.

Trading Symbol: IVTY
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 1,807,239 shares
Current Value: $12,650,673
Latest Transaction: Dec 14 2016
$IVTY Market Capitalization: $117.66M
$IVTY Previous Close: $7.00

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL

Last 3 Months Overview:
Buy: 0x
Sell: 3x
Shares Bought: 0
Shares Sold: 184,796
Share Difference: -184,796
Value Difference: +$1,148,909

Latest Insider Trading Transactions of James E Flynn in Invuity, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 14 2016IVTYInvuity, Inc.Flynn James E10% OwnerSellS6.0145,568273,6771,690,4981.7 M to 1.7 M (-2.62 %)
Dec 14 2016IVTYInvuity, Inc.Flynn James E10% OwnerSellS6.1371,173436,1481,736,0661.8 M to 1.7 M (-3.94 %)
Dec 14 2016IVTYInvuity, Inc.Flynn James E10% OwnerSellS6.4568,055439,0841,807,2391.9 M to 1.8 M (-3.63 %)

Page:   1